XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Contracts and Concentrations - Qurate Agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Product Information [Line Items]          
Net revenue $ 2,637 $ 4,501 $ 15,468 $ 21,715  
Accounts receivable 4,749   4,749   $ 5,110
Net licensing revenue          
Product Information [Line Items]          
Net revenue $ 2,381 $ 2,166 $ 7,031 $ 13,302  
Sales [Member] | Customer Concentration Risk [Member] | Qurate          
Product Information [Line Items]          
Concentration Risk, Percentage 61.00% 31.00% 32.00% 48.00%  
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue          
Product Information [Line Items]          
Net revenue $ 1,610 $ 1,400 $ 4,900 $ 10,470  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate          
Product Information [Line Items]          
Concentration Risk, Percentage     34.00%   17.00%
Accounts receivable $ 1,600   $ 1,600   $ 900